Related Experiment Videos
Gonadotropin-releasing hormone antagonists.
1UCLA School of Medicine, Department of Internal Medicine, Augustus F Hawkins Building, Room 3069, 1731 East 120th Street, Los Angeles, CA 90059, USA. kaherbst@cdrewu.edu
Current Opinion in Pharmacology
|December 3, 2003
Summary
Gonadotropin-releasing hormone (GnRH) antagonists block GnRH receptors, leading to reduced hormone secretion. These antagonists show promise for treating various conditions, including cancer and infertility.
Area of Science:
- Endocrinology
- Reproductive Medicine
- Oncology
Background:
- Hypothalamic gonadotropin-releasing hormone (GnRH) regulates reproductive functions by stimulating pituitary gonadotropin release.
- GnRH antagonists function by blocking GnRH receptors, effectively inhibiting this pathway.
- Current research explores both peptide and non-peptide GnRH antagonists.
Purpose of the Study:
- To review the mechanism of action and therapeutic potential of GnRH antagonists.
- To highlight the expanding applications of GnRH antagonists beyond assisted reproduction.
Main Methods:
- Literature review of GnRH antagonist formulations and clinical applications.
- Analysis of pharmacological mechanisms including receptor binding inhibition.
- Exploration of potential future therapeutic uses.
Main Results:
- Thousands of GnRH antagonists have been formulated, with many in clinical trials or approved.
- GnRH antagonists induce pharmacological hypophysectomy by blocking GnRH receptors.
- Potential applications include treatment of hormone-dependent diseases, male contraception, and cancer therapy.
Conclusions:
- GnRH antagonists represent a significant therapeutic advancement.
- Their utility is expected to broaden to diverse medical fields.
- Further research will likely expand the clinical use of GnRH antagonists.